HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

dryocrassin

Networked: 8 relevant articles (3 outcomes, 2 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Ketones: 2618
  - Cyclohexanones: 5
    - dryocrassin: 8
- Hydrocarbons: 1713
  - Cyclic Hydrocarbons: 97
    - Aromatic Hydrocarbons: 291
      - Benzene Derivatives: 17
        Benzylidene Compounds: 10
        dryocrassin: 8
    - Alicyclic Hydrocarbons: 1
      - Cycloparaffins: 6
        Cyclohexanes: 3
        Cyclohexanones: 5
        dryocrassin: 8

Experts

1.	Jang, Min Seong: 1 article (02/2022)
2.	Jeon, Sangeun: 1 article (02/2022)
3.	Jin, Young-Hee: 1 article (02/2022)
4.	Kim, Hyoung Rae: 1 article (02/2022)
5.	Kim, Seungtaek: 1 article (02/2022)
6.	Kwon, Sunoh: 1 article (02/2022)
7.	Lee, Jihye: 1 article (02/2022)
8.	Park, Chul Min: 1 article (02/2022)
9.	Song, Jong Hwan: 1 article (02/2022)
10.	Deng, Xuming: 1 article (01/2021)

Related Diseases

1.	Influenza in Birds (Avian Flu) 01/01/2015 - "Based on the above we conclude that orally administered dryocrassin ABBA provided mice protection against avian influenza virus H5N1 by inhibiting inflammation and reducing virus loads. " 01/01/2019 - "This study suggested that dryocrassin ABBA and its analogues especially AB, which consisted of polyphenol groups may have beneficial effects on treating avian influenza H7N9 virus." 01/01/2015 - "Dryocrassin ABBA is a potential novel lead compound which had antiviral effects on amantadine-resistant avian influenza virus H5N1 infection. "
2.	Infections 03/08/2017 - "crassirhizoma were shown to have anti-influenza virus activity, and especially dryocrassin ABBA, one of the phloroglucinols, may have the potential to control influenza virus (H5N1) infection." 01/01/2021 - "Dryocrassin ABBA ameliorates Streptococcus pneumoniae-induced infection in vitro through inhibiting Streptococcus pneumoniae growth and neutralizing pneumolysin activity." 02/08/2022 - "crassirhizoma, dryocrassin ABBA and filixic acid ABA were reported to inhibit influenza virus infection with an inhibitory activity on neuraminidase. " 01/01/2015 - "Dryocrassin ABBA is a potential novel lead compound which had antiviral effects on amantadine-resistant avian influenza virus H5N1 infection. "
3.	Coronavirus Infections 02/08/2022 - "Therefore, dryocrassin ABBA has therapeutic potential against emerging coronavirus infections, including COVID-19."
4.	Inflammation (Inflammations) 01/01/2015 - "Based on the above we conclude that orally administered dryocrassin ABBA provided mice protection against avian influenza virus H5N1 by inhibiting inflammation and reducing virus loads. "
5.	COVID-19 02/08/2022 - "Therefore, dryocrassin ABBA has therapeutic potential against emerging coronavirus infections, including COVID-19." 02/08/2022 - "Therefore, dryocrassin ABBA and filixic acid ABA exhibited inhibitory activity against SARS-CoV-2 infection in Vero cells dose-dependently using the immunofluorescence-based antiviral assays. "

Related Drugs and Biologics

1.	Streptococcus pneumoniae plY protein
2.	Polyphenols
3.	Antiviral Agents (Antivirals)
4.	Caspases
5.	Neuraminidase (Sialidase)
6.	Amantadine (Aman)
7.	filicin